Development

INSIGHTS ON DRUG DEVELOPMENT

Navigating The Regulatory Space To Biosimilar Approval
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
Cell Culture Media Demystified For Performance, Quality, And Innovation
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
Beyond SOPs: Assessing Quality Of CDMOs
When choosing a CDMO partner, it is essential to prioritize quality. Discover how the right partner can instill confidence in the safety and effectiveness of your pharmaceutical products.
Best-In-Class Nanodevelopment Capabilities
A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.

5 Key Considerations For Companies Outsourcing Process Development
6/9/2025

Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
Scale Your Viral Vector Production With A Streamlined Bioreactor System
11/4/2025

Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
A Digital Dispenser For Single-Cell And Low-Input Proteomics
11/7/2025

Discover a high-precision dispensing system that enables rapid, low-volume sample prep for single-cell proteomics to support flexible workflows, maintain cell integrity, and deliver reliable results.
Particles In High Concentration Biotherapeutics
8/7/2025

Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.
Development Of A High Sensitivity SPE-LC-MS/MS Assay
7/29/2025

Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.

Protect Your Lab Instruments From Expected Downtime With FlexCHOICE Service Coverage

Access all the service, support, and performance maintenance options you need for uninterrupted performance – giving your lab more control over your service, maintenance costs, and enabling you to optimize your laboratory productivity.
Unlocking Pharmaceutical Success: From Idea To Reality

In the pharmaceutical industry, every capsule and tablet begins with a concept. Transforming that idea into a tangible product requires an expert manufacturing partner. Natoli stands out as a leader in pharmaceutical equipment and services, providing a comprehensive journey from formulation to full-scale production.
Oligonucleotide CDMO: From Preclinical To Commercial

See how flexible synthesis platforms, structured CMC strategies, and advanced purification tools boost scalability, control impurities, and strengthen readiness for clinical and commercial oligo programs.
Keep A Close Eye On Quality With Excipients For Drug Formulation

Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
Accelerate Drug Development With Reliable Pharmaceutical Research

Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.